Drug shortages: These factors lead to supply bottlenecks in the pharmaceutical industry

Competition between generics manufacturers makes supply chains more vulnerable

31-Mar-2023 - In a recent study, Prof. Dr. Kai Hoberg (KLU), Prof. Dr. David Francas (University of Applied Sciences Worms) and Stephan Mohr (Frankfurt School of Finance and Management) looked into which conditions affect the availability of drugs in Germany. One key finding: while competition between generics ...

Merck Announces VAR2 Pharmaceuticals as Winner of its Advance Biotech Grant

VAR2 Pharmaceuticals selected for its development of a drug-conjugated malaria protein

10-Jul-2020 - Merck, a leading science and technology company, today announced that VAR2 Pharmaceuticals has been selected as the European winner of its 2020 Advance Biotech Grant Program. Copenhagen, Denmark-based biotechnology company VAR2 Pharmaceuticals was chosen for its development of a promising novel ...

Eisai commences full-scale operation of new production site

Strengthening in-house domestic production system in China

09-Nov-2018 - Eisai Co., Ltd. announced that its Chinese subsidiary, Eisai China Inc. (ECI) has commenced full-scale operation of its new Suzhou plant located within the Suzhou Industrial Park, and an opening ceremony was held accordingly. Aiming to further expand its contribution to patients in China, Eisai ...

Milestone Pharmaceuticals Announces $80 Million Private Financing

30-Oct-2018 - Milestone Pharmaceuticals, a late-stage biopharmaceutical company developing interventions for tachycardias, announced the completion of an $80 million private financing. The equity financing included the support of new and existing institutional investors. Among new investors were RTW ...

Price competition for generic drugs linked to increase in manufacturing-related recalls

01-Jun-2018 - Researchers from three universities have found that extreme price competition in the generic pharmaceutical market -- designed to make medications more affordable -- may be putting more patients at serious health risk, as evidenced by a higher number of product recalls caused by ...

GSK transfers rare disease gene therapy portfolio

13-Apr-2018 - GSK and Orchard Therapeutics announced a strategic agreement, under which GSK will transfer its portfolio of approved and investigational rare disease gene therapies to Orchard, securing the continued development of the programmes and access for patients. This acquisition strengthens Orchard’s ...

Challenging counterfeit products with rare earths

New marking technique could halt product piracy

29-Jan-2018 - Researchers at the University of Copenhagen have developed the world's most secure marking system for combatting pirated goods including pirated pharmaceuticals, foodstuffs, designer merchandise and artwork. The system could be on the market in a year and because the markings are random, it ...

Zelluna Immunotherapy appoints Miguel Forte as Chief Executive Officer

Appointment to drive Zelluna through next stage of international clinical-phase development

03-Nov-2017 - Zelluna Immunotherapy,the biotechnology company specializing in T-cell receptor (TCR) immunotherapies targeting a broad range of solid cancers with a high unmet medical need, today announces the appointment of Miguel Forte as chief executive officer (CEO). “Zelluna is developing a unique ...

VirionHealth Raises Series A Funding from Abingworth

13-Oct-2017 - VirionHealth Ltd, a new biotechnology company developing novel therapeutics for respiratory viral infections, today announced that it has raised up to £13 million in Series A funding from Abingworth, the international investment group dedicated to life sciences. VirionHealth, founded on ...

Merck Invests in its Biotech Manufacturing Site in Bari

New production line for the aseptic filling of biotech medicines under isolator

04-Oct-2017 - Merck will invest €35 million in a new production line for the aseptic filling of biotech medicines under isolator at its manufacturing site of Bari, Italy. The announcement was made as part of an event celebrating the 25th anniversary of the site and its leading role on the science and ...